THOXDRO Trademark

Trademark Overview

On Wednesday, April 9, 2025, a trademark application was filed for THOXDRO with the United States Patent and Trademark Office. The USPTO has given the THOXDRO trademark a serial number of 99129316. The federal status of this trademark filing is PUBLICATION/ISSUE REVIEW COMPLETE as of Monday, September 15, 2025. This trademark is owned by CivicaScript, LLC. The THOXDRO trademark is filed in the Pharmaceutical Products category with the following description:

pharmaceutical products for the treatment of central nervous system diseases and disorders; pharmaceutical products for the treatment of vertigo, dizziness, and lightheadedness; pharmaceutical products for the treatment of symptomatic neurogenic orthostatic hypotension; pharmaceutical products for the treatment of symptoms caused by primary autonomic failure, dopamine beta-hydroxylase deficiency, and non-diabetic autonomic neuropathy; pharmaceutical products for the treatment of symptoms caused by Parkinson’s disease, multiple system atrophy, and pure autonomic failure
thoxdro

General Information

Serial Number99129316
Word MarkTHOXDRO
Filing DateWednesday, April 9, 2025
Status681 - PUBLICATION/ISSUE REVIEW COMPLETE
Status DateMonday, September 15, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, October 7, 2025

Trademark Statements

Goods and Servicespharmaceutical products for the treatment of central nervous system diseases and disorders; pharmaceutical products for the treatment of vertigo, dizziness, and lightheadedness; pharmaceutical products for the treatment of symptomatic neurogenic orthostatic hypotension; pharmaceutical products for the treatment of symptoms caused by primary autonomic failure, dopamine beta-hydroxylase deficiency, and non-diabetic autonomic neuropathy; pharmaceutical products for the treatment of symptoms caused by Parkinson’s disease, multiple system atrophy, and pure autonomic failure

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, April 9, 2025
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameCivicaScript, LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressLehi, UT 84043

Trademark Events

Event DateEvent Description
Wednesday, April 9, 2025NEW APPLICATION ENTERED
Wednesday, April 9, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, September 4, 2025ASSIGNED TO EXAMINER
Thursday, September 4, 2025APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 9, 2025APPLICATION FILING RECEIPT MAILED

Related Keywords

thoxdro pharmaceutical treatment products autonomic caused failure symptoms system deficiency diabetic